Active Ingredient: OXALIPLATIN
Proprietary Name: OXALIPLATIN
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 100MG/20ML (5MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A217348
Product Number: 002
Approval Date: Jan 11, 2024
Applicant Holder Full Name: KINDOS PHARMACEUTICALS CO LTD
Marketing Status:
Prescription
Patent and Exclusivity Information